NeuroSense Therapeutics (NRSN) Stock News
$NRSN · NASDAQ · 2 stories in 30 days$3.07
1D +1.99%1W −14.25%1M −49.42%
BORSA has published 2 stories on NeuroSense Therapeutics (NRSN) in the past 30 days. BORSA’s news read on NRSN is leaning bullish at 56/100, unchanged over 24 hours, based on 2 company events over the past 7 days. NRSN last closed at $3.49 on Oct 13, down 14.25% over five sessions and down 49.42% over the past month.
The wire on $NRSN
newest first · updated · direct subject stories onlyNeuroSense Therapeutics shares continue to trade on Nasdaq pending panel decision
NeuroSense Therapeutics (NRSN) shares remain listed on Nasdaq as a panel reviews the company's compliance status. The outcome will decide continued listing.
neutral 50 · impact 40